申请人:Macdonald Gregor James
公开号:US20120238561A1
公开(公告)日:2012-09-20
The present invention relates to morpholinothiazole derivatives and pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy. The invention particularly relates to positive allosteric modulators of nicotinic acetylcholine receptors, such positive allosteric modulators having the capability to increase the efficacy of nicotinic receptor agonists.
本发明涉及吗啉噻唑衍生物及其可药用盐,它们的制备方法,含有它们的药物组合物及其在治疗中的用途。特别是涉及烟酸乙酰胆碱受体的正变构调节剂,这些正变构调节剂具有增加烟酸受体激动剂效力的能力。